_id

69109428ccc777a4e85d5a77

Ticker

EDIT

Name

Editas Medicine Inc

Exchange

NASDAQ

Address

11 Hurley Street, Cambridge, MA, United States, 02141

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.editasmedicine.com

Description

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

Last Close

2.56

Volume

1014521

Current Price

2.515

Change

-1.7578124999999973

Last Updated

2025-11-29T12:33:46.236Z

Image

data:image/webp;base64,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

Ipo Date

2016-02-03T00:00:00.000Z

Market Cap

235260976

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9955

Sentiment Sources

8

Rating

3.4667

Target Price

5.125

Strong Buy

4

Buy

1

Hold

8

Sell

2

Strong Sell

0

Current Quarter

2025-09-30

Revenue

7543000

Cost Of Revenue

-

Gross Profit

7543000

Operating Expenses

32091000

Operating Income

-24548000

Interest Expense

2399000

Pretax Income

-25117000

Net Income

-25117000

Eps

-0.2787977502197043

Dividends Per Share

-

Shares Outstanding

97618660

Income Tax Expense

-

EBITDA

-21997000

Operating Margin

-325.4408060453401

Total Other Income Expense Net

-569000

Cash

165648000

Short Term Investments

0

Receivables

8130000

Inventories

-

Total Current Assets

176891000

Property Plant Equipment

21870000

Total Assets

201751000

Payables

3163000

Short Term Debt

6088000

Long Term Debt

-

Total Liabilities

188298000

Equity

13453000

Depreciation

721000

Change In Working Capital

-11012000

Cash From Operations

-30843000

Capital Expenditures

433000

Cash From Investing

39573000

Cash From Financing

17169000

Net Change In Cash

25899000

PE

-

PB

16.84214290158329

ROE

-186.7018508882777

ROA

-12.449504587337858

FCF

-31276000

Fcf Percent

-4.146360864377568

Piotroski FScore

0

Health Score

8

Deep Value Investing Score

3.5

Defensive Investing Score

5.5

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

3

Growth Investing Score

3

Momentum Investing Score

4

Net Net Investing Score

3

Quality Investing Score

1.5

Value Investing Score

2

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

7543000

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

7543000

Quarters > 0 > income Statement > operating Expenses

32091000

Quarters > 0 > income Statement > operating Income

-24548000

Quarters > 0 > income Statement > interest Expense

2399000

Quarters > 0 > income Statement > pretax Income

-25117000

Quarters > 0 > income Statement > net Income

-25117000

Quarters > 0 > income Statement > eps

-0.2787977502197043

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

90090397

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-21997000

Quarters > 0 > income Statement > operating Margin

-325.4408060453401

Quarters > 0 > income Statement > total Other Income Expense Net

-569000

Quarters > 0 > balance Sheet > cash

165648000

Quarters > 0 > balance Sheet > short Term Investments

0

Quarters > 0 > balance Sheet > receivables

8130000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

176891000

Quarters > 0 > balance Sheet > property Plant Equipment

21870000

Quarters > 0 > balance Sheet > total Assets

201751000

Quarters > 0 > balance Sheet > payables

3163000

Quarters > 0 > balance Sheet > short Term Debt

6088000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

188298000

Quarters > 0 > balance Sheet > equity

13453000

Quarters > 0 > cash Flow > net Income

-25117000

Quarters > 0 > cash Flow > depreciation

721000

Quarters > 0 > cash Flow > change In Working Capital

-11012000

Quarters > 0 > cash Flow > cash From Operations

-30843000

Quarters > 0 > cash Flow > capital Expenditures

433000

Quarters > 0 > cash Flow > cash From Investing

39573000

Quarters > 0 > cash Flow > cash From Financing

17169000

Quarters > 0 > cash Flow > net Change In Cash

25899000

Quarters > 0 > ratios > PE

-0.2787977502197043

Quarters > 0 > ratios > PB

16.84214290158329

Quarters > 0 > ratios > ROE

-186.7018508882777

Quarters > 0 > ratios > ROA

-12.449504587337858

Quarters > 0 > ratios > FCF

-31276000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-4.146360864377568

Quarters > 0 > health Score

8

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

3578000

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

3578000

Quarters > 1 > income Statement > operating Expenses

55122000

Quarters > 1 > income Statement > operating Income

-51544000

Quarters > 1 > income Statement > interest Expense

2020000

Quarters > 1 > income Statement > pretax Income

-53235000

Quarters > 1 > income Statement > net Income

-53235000

Quarters > 1 > income Statement > eps

-0.630655284425711

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

84412200

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-49381000

Quarters > 1 > income Statement > operating Margin

-1440.581330352152

Quarters > 1 > income Statement > total Other Income Expense Net

-1691000

Quarters > 1 > balance Sheet > cash

138542000

Quarters > 1 > balance Sheet > short Term Investments

39959000

Quarters > 1 > balance Sheet > receivables

588000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

182796000

Quarters > 1 > balance Sheet > property Plant Equipment

23587000

Quarters > 1 > balance Sheet > total Assets

210581000

Quarters > 1 > balance Sheet > payables

6723000

Quarters > 1 > balance Sheet > short Term Debt

6146000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

191392000

Quarters > 1 > balance Sheet > equity

19189000

Quarters > 1 > cash Flow > net Income

-53235000

Quarters > 1 > cash Flow > depreciation

1577000

Quarters > 1 > cash Flow > change In Working Capital

-4620000

Quarters > 1 > cash Flow > cash From Operations

-50212000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

42650000

Quarters > 1 > cash Flow > cash From Financing

7412000

Quarters > 1 > cash Flow > net Change In Cash

-150000

Quarters > 1 > ratios > PE

-0.630655284425711

Quarters > 1 > ratios > PB

11.06345734535411

Quarters > 1 > ratios > ROE

-277.4245661576945

Quarters > 1 > ratios > ROA

-25.280058504803378

Quarters > 1 > ratios > FCF

-50212000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-14.033538289547232

Quarters > 1 > health Score

9

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

4658000

Quarters > 2 > income Statement > cost Of Revenue

907000

Quarters > 2 > income Statement > gross Profit

4658000

Quarters > 2 > income Statement > operating Expenses

80821000

Quarters > 2 > income Statement > operating Income

-76163000

Quarters > 2 > income Statement > interest Expense

2216000

Quarters > 2 > income Statement > pretax Income

-76088000

Quarters > 2 > income Statement > net Income

-76088000

Quarters > 2 > income Statement > eps

-0.9161150988670577

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

83055066

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-71955000

Quarters > 2 > income Statement > operating Margin

-1635.1009016745384

Quarters > 2 > income Statement > total Other Income Expense Net

75000

Quarters > 2 > balance Sheet > cash

138692000

Quarters > 2 > balance Sheet > short Term Investments

82272000

Quarters > 2 > balance Sheet > receivables

510000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

224843000

Quarters > 2 > balance Sheet > property Plant Equipment

34611000

Quarters > 2 > balance Sheet > total Assets

263652000

Quarters > 2 > balance Sheet > payables

5465000

Quarters > 2 > balance Sheet > short Term Debt

13161000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

201232000

Quarters > 2 > balance Sheet > equity

62420000

Quarters > 2 > cash Flow > net Income

-76088000

Quarters > 2 > cash Flow > depreciation

1917000

Quarters > 2 > cash Flow > change In Working Capital

17615000

Quarters > 2 > cash Flow > cash From Operations

-47799000

Quarters > 2 > cash Flow > capital Expenditures

114000

Quarters > 2 > cash Flow > cash From Investing

56387000

Quarters > 2 > cash Flow > cash From Financing

-1437000

Quarters > 2 > cash Flow > net Change In Cash

7151000

Quarters > 2 > ratios > PE

-0.9161150988670577

Quarters > 2 > ratios > PB

3.3464192725088115

Quarters > 2 > ratios > ROE

-121.89682793976289

Quarters > 2 > ratios > ROA

-28.859253864943184

Quarters > 2 > ratios > FCF

-47913000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-10.286174323744095

Quarters > 2 > health Score

12

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

30604000

Quarters > 3 > income Statement > cost Of Revenue

1381000

Quarters > 3 > income Statement > gross Profit

30604000

Quarters > 3 > income Statement > operating Expenses

77197000

Quarters > 3 > income Statement > operating Income

-46593000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-45395000

Quarters > 3 > income Statement > net Income

-45395000

Quarters > 3 > income Statement > eps

-0.5494842625080539

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

82613831

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-32980000

Quarters > 3 > income Statement > operating Margin

-152.2448046007058

Quarters > 3 > income Statement > total Other Income Expense Net

1198000

Quarters > 3 > balance Sheet > cash

131541000

Quarters > 3 > balance Sheet > short Term Investments

138372000

Quarters > 3 > balance Sheet > receivables

16266000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

289315000

Quarters > 3 > balance Sheet > property Plant Equipment

47051000

Quarters > 3 > balance Sheet > total Assets

341589000

Quarters > 3 > balance Sheet > payables

5493000

Quarters > 3 > balance Sheet > short Term Debt

14652000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

207315000

Quarters > 3 > balance Sheet > equity

134274000

Quarters > 3 > cash Flow > net Income

-45395000

Quarters > 3 > cash Flow > depreciation

1381000

Quarters > 3 > cash Flow > change In Working Capital

-12099000

Quarters > 3 > cash Flow > cash From Operations

-50762000

Quarters > 3 > cash Flow > capital Expenditures

540000

Quarters > 3 > cash Flow > cash From Investing

30958000

Quarters > 3 > cash Flow > cash From Financing

55513000

Quarters > 3 > cash Flow > net Change In Cash

35709000

Quarters > 3 > ratios > PE

-0.5494842625080539

Quarters > 3 > ratios > PB

1.5473865749512192

Quarters > 3 > ratios > ROE

-33.80773641956

Quarters > 3 > ratios > ROA

-13.289362362371154

Quarters > 3 > ratios > FCF

-51302000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-1.676316821330545

Quarters > 3 > health Score

24

Valuation > metrics > PE

-0.2787977502197043

Valuation > metrics > PB

16.84214290158329

Valuation > final Score

20

Valuation > verdict

461.4% Overvalued

Profitability > metrics > ROE

-186.7018508882777

Profitability > metrics > ROA

-14.199139583133116

Profitability > metrics > Net Margin

-3.3298422378364045

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

13.996729354047424

Risk > metrics > Interest Coverage

-10.232596915381409

Risk > final Score

-35

Risk > verdict

High

Liquidity > metrics > Current Ratio

19.12128418549346

Liquidity > metrics > Quick Ratio

19.12128418549346

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

46.53580727491188

Prev Valuations > 2

80

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-96

Prev Risks > 1

-131

Prev Risks > 2

15

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-13T00:36:31.334Z